---

Matthew Todd

Associate Professor, University of Sydney; Founder, Open Source Malaria

Matthew would love to see a “robust and large-scale trial of open source drug development as a competing model for the pharmaceutical industry, funded through a mixed investment model of public, private and philanthropic support.” His passion is to improve efficiency in R&D through working with others, and making knowledge more available.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018